TAZORAC Drug Patent Profile

When do Tazorac patents expire, and what generic alternatives are available?

Tazorac is a drug marketed by Allergan and is included in two NDAs.

The generic ingredient in TAZORAC is tazarotene. There are eight drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the tazarotene profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Tazorac

A generic version of TAZORAC was approved as tazarotene by TARO on April 3^rd, 2017.

Summary for TAZORAC

US Patents:	0
Applicants:	1
NDAs:	2
Finished Product Suppliers / Packagers:	3
Raw Ingredient (Bulk) Api Vendors:	79
Clinical Trials:	21
Patent Applications:	4,437
Drug Prices:	Drug price information for TAZORAC
What excipients (inactive ingredients) are in TAZORAC?	TAZORAC excipients list
DailyMed Link:	TAZORAC at DailyMed

See drug prices for TAZORAC

See drug sales revenues for TAZORAC

Recent Clinical Trials for TAZORAC

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Dana-Farber Cancer Institute	Phase 2
Bayer	Phase 2
Dr. Reddy's Laboratories Limited	Phase 2

See all TAZORAC clinical trials

Pharmacology for TAZORAC

Drug Class

Retinoid

US Patents and Regulatory Information for TAZORAC

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Allergan	TAZORAC	tazarotene	CREAM;TOPICAL	021184-001	Sep 29, 2000	AB	RX	Yes	Yes
Allergan	TAZORAC	tazarotene	GEL;TOPICAL	020600-002	Jun 13, 1997	AB	RX	Yes	Yes
Allergan	TAZORAC	tazarotene	CREAM;TOPICAL	021184-002	Sep 29, 2000	AB	RX	Yes	Yes
Allergan	TAZORAC	tazarotene	GEL;TOPICAL	020600-001	Jun 13, 1997	AB	RX	Yes	Yes

Expired US Patents for TAZORAC

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Allergan	TAZORAC	tazarotene	GEL;TOPICAL	020600-001	Jun 13, 1997
Allergan	TAZORAC	tazarotene	CREAM;TOPICAL	021184-001	Sep 29, 2000
Allergan	TAZORAC	tazarotene	GEL;TOPICAL	020600-002	Jun 13, 1997
Allergan	TAZORAC	tazarotene	GEL;TOPICAL	020600-002	Jun 13, 1997
Allergan	TAZORAC	tazarotene	GEL;TOPICAL	020600-001	Jun 13, 1997
Allergan	TAZORAC	tazarotene	GEL;TOPICAL	020600-001	Jun 13, 1997
Allergan	TAZORAC	tazarotene	CREAM;TOPICAL	021184-002	Sep 29, 2000

International Patents for TAZORAC

See the table below for patents covering TAZORAC around the world.

Country	Patent Number	Title	Estimated Expiration
Germany	69330092
Denmark	1147778
Canada	2191773	COMPOSITION DE GEL STABLE POUR LE TRAITEMENT TOPIQUE DE MALADIES DE LA PEAU (STABLE GEL FORMULATION FOR TOPICAL TREATMENT OF SKIN CONDITIONS)
Germany	69535184
Germany	3871414
Australia	3659193
Denmark	175081

Supplementary Protection Certificates for TAZORAC

Patent Number	Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
0031058	98C0008	Belgium		PRODUCT NAME: TAZAROTENE; NAT. REGISTRATION NO/DATE: NL22604 19970922; FIRST REGISTRATION: DE - 37393.00.00 19961203
0284288	12/1998	Austria		PRODUCT NAME: TAZAROTENE; NAT. REGISTRATION NO/DATE: 1-22102, 1-22103 19970918; FIRST REGISTRATION: DE 37393.00.00, 37393.01.00 19961203
0284288	SPC/GB98/002	United Kingdom		PRODUCT NAME: TAZAROTENE : ETHYL 6-(2-(4,4-DIMETHYLTHIOCHROMAN-6-YL) ETHYNYL) NICOTINOATE; REGISTERED: DE 37393.00.00 19961203; DE 37393.01.00 19961203; UK 00426/0097 19970730; UK 00426/0096 19970730

TAZORAC Market Analysis and Financial Projection Experimental

Tazarotene Market Dynamics and Financial Trajectory: A Comprehensive Overview

Introduction to Tazarotene

Tazarotene, a synthetic retinoid, is widely used in the treatment of various skin disorders, including psoriasis, acne, and photoaged skin. The market for tazarotene is experiencing significant growth, driven by several key factors.

Market Drivers

Increasing Prevalence of Skin Disorders

The rising incidence of skin disorders such as psoriasis and acne is a major driver for the tazarotene market. As the global population becomes more aware of the available treatment options, the demand for effective and safe treatments is increasing[1].

Advancements in Dermatological Research

Ongoing research and development in dermatology are leading to the introduction of innovative and advanced therapies. Tazarotene, with its proven efficacy in managing various skin conditions, is gaining popularity among healthcare professionals and patients[1].

Growing Demand for Targeted Therapies

There is a growing demand for targeted therapies in dermatology that offer improved outcomes and reduced side effects. Tazarotene's specific mechanism of action makes it a preferred choice, contributing to its market growth[1].

Market Restraints

Regulatory and Competitive Landscape

The tazarotene market is influenced by a complex regulatory landscape and intense competition. The availability of generic versions of tazarotene can also impact the market dynamics, as these offer cost-effective alternatives[1].

COVID-19 Impact

The COVID-19 pandemic had a mixed impact on the tazarotene market. While there was a temporary slowdown due to disruptions in healthcare systems and reduced patient visits, the demand for tazarotene products remained stable due to the chronic nature of skin conditions[1].

Regional Analysis

North America

North America currently dominates the tazarotene market, driven by the high prevalence of skin disorders and the presence of established market players in the region. The strong healthcare infrastructure and high awareness about dermatological treatments also contribute to this dominance[1].

Asia Pacific

The Asia Pacific region is expected to witness significant growth during the forecast period. This growth is attributed to the increasing awareness about dermatological treatments and the improving healthcare infrastructure in the region[1].

End-User Analysis

Dermatology Clinics and Hospitals

Dermatology clinics and hospitals are the major end-users of tazarotene products, contributing significantly to market revenue. These institutions play a crucial role in the diagnosis and treatment of skin disorders, driving the demand for tazarotene[1].

Financial Trajectory

Revenue and Growth

The tazarotene market is expected to witness a healthy Compound Annual Growth Rate (CAGR) during the forecast period. The market growth is driven by the increasing demand for effective and targeted dermatological treatments. The revenue is expected to increase steadily, fueled by the growing prevalence of skin disorders and advancements in dermatological research[1][4].

Key Financial Metrics

• Revenue: The market revenue is anticipated to grow significantly, driven by the increasing adoption of tazarotene in various dermatological treatments.
• Production Growth Rate: The production of tazarotene is expected to increase to meet the growing demand, particularly with the introduction of innovative formulations such as foams and sprays[1][4].
• Market Share: Key players in the market are expected to maintain or increase their market share through strategic collaborations, research and development, and the launch of new formulations[4].

Company Profiles and Innovations

Launch of Novel Formulations

Market players have introduced innovative tazarotene formulations to improve patient convenience and treatment outcomes. For example, the launch of foams and sprays has enhanced the usability and efficacy of tazarotene treatments[1].

Strategic Collaborations

Key industry players have engaged in strategic collaborations with research institutions and dermatology associations to advance the development and adoption of tazarotene-based therapies. These collaborations are crucial for driving market growth and addressing unmet medical needs[1].

Competitive Landscape

The tazarotene market is highly competitive, with several key players vying for market share. Companies like Allergan and Almirall are significant players in this market, with a strong focus on research and development and strategic collaborations to enhance their market presence[1][3].

Future Outlook

The future outlook for the tazarotene market is positive, driven by ongoing research and development activities, market penetration in emerging regions, and patient education programs. The market is expected to continue growing as the demand for effective and targeted dermatological treatments increases[1].

Key Takeaways

• The tazarotene market is driven by the increasing prevalence of skin disorders and advancements in dermatological research.
• North America dominates the market, but the Asia Pacific region is expected to show significant growth.
• Dermatology clinics and hospitals are major end-users, contributing significantly to market revenue.
• The market is expected to witness steady growth, driven by the launch of novel formulations and strategic collaborations.
• The COVID-19 pandemic had a mixed impact, but the market is expected to regain momentum as the situation normalizes.

FAQs

What are the primary drivers of the tazarotene market?

The primary drivers include the increasing prevalence of skin disorders, advancements in dermatological research, and the growing demand for targeted therapies[1].

Which region dominates the tazarotene market?

North America currently dominates the tazarotene market due to the high prevalence of skin disorders and the presence of established market players[1].

How has the COVID-19 pandemic affected the tazarotene market?

The COVID-19 pandemic had a mixed impact, with a temporary slowdown due to healthcare disruptions, but the demand for tazarotene remained stable due to the chronic nature of skin conditions[1].

What are the key innovations in tazarotene formulations?

Key innovations include the launch of novel formulations such as foams and sprays to improve patient convenience and treatment outcomes[1].

Who are the major end-users of tazarotene products?

Dermatology clinics and hospitals are the major end-users, contributing significantly to market revenue[1].

Cited Sources:

1. MarkWide Research - Tazarotene Market 2024-2032 | Size, Share, Growth
2. Allergan - Allergan Reports Fourth Quarter and Full-Year 2018 Financial Results
3. Almirall - Annual Reports
4. NewsChannel Nebraska - Tazarotene Market Outlook: Key Players, Segmentation, Growth Factors, and Forecast 2032